熱門資訊> 正文

Absci大举收购礼来、私募股权投资

2026-06-24 19:25

Absci (ABSI) is up ~20% in premarket trading Monday after announcing $100M in financing from Eli Lilly (LLY) as well as several private equity firms.
The biopharma has priced an underwritten offering of 13,495,277 shares at $7.41 per share.
Adage, BVF Partners, Columbia Threadneedle, Invus, and Redmile are among the private equity investors.
Absci said it will use the proceeds to support ABS-201, its anti-PRLR antibodyfor androgenetic alopecia (pattern hair loss) and endometriosis, as well as working capital and general corporate purposes.

More on Absci

Absci Corporation (ABSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Slideshow
Absci Corporation (ABSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript
Absci Corporation: A Big Binary Approaching In Alopecia
Absci rises after early-stage trial data for hair loss therapy and $100M stock offering
Absci climbs after New Outperform at Leerink on catalyst path

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。